These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8248919)

  • 21. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
    Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
    Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
    Hernández C; Chacón P; García-Pascual L; Simó R
    Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased concentrations of serum Lp(a) lipoprotein in patients with primary gout.
    Takahashi S; Yamamoto T; Moriwaki Y; Tsutsumi Z; Higashino K
    Ann Rheum Dis; 1995 Feb; 54(2):90-3. PubMed ID: 7702412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men.
    Bremner WF; Sothern RB; Kanabrocki EL; Ryan M; McCormick JB; Dawson S; Connors ES; Rothschild R; Third JL; Vahed S; Nemchausky BM; Shirazi P; Olwin JH
    Am Heart J; 2000 Jan; 139(1 Pt 1):164-73. PubMed ID: 10618578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of combination therapy with niceritrol and pravastatin on hyperlipidaemia.
    Kinoshita M; Mikuni Y; Kudo M; Mori M; Horie E; Teramoto T; Matsushima T
    J Int Med Res; 2002; 30(3):271-81. PubMed ID: 12166344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
    Cantin B; Després JP; Lamarche B; Moorjani S; Lupien PJ; Bogaty P; Bergeron J; Dagenais GR
    Am J Cardiol; 2002 Mar; 89(6):662-6. PubMed ID: 11897206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes of blood lipids in colorectal cancer patients with coronary heart disease and value of lipid-lowering therapy with statins].
    Liang ZT; Wang XP; Zeng QT; Liao YH; Gao CY; Li MW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):863-5. PubMed ID: 18504222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
    Yamamoto K; Fukushima N; Ozaki I; Setoguchi Y; Yanagita T; Sakai T
    Artery; 1991; 18(3):133-49. PubMed ID: 2069518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
    Ma L; Waldmann E; Ooi EMM; Chan DC; Barrett HPR; Watts GF; Parhofer KG
    Eur J Clin Invest; 2019 Feb; 49(2):e13053. PubMed ID: 30447089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography.
    Labeur C; De Bacquer D; De Backer G; Vincke J; Muyldermans L; Vandekerckhove Y; Van der Stichele E; Rosseneu M
    Clin Chem; 1992 Nov; 38(11):2261-6. PubMed ID: 1424121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).
    Maher VM; Brown BG; Marcovina SM; Hillger LA; Zhao XQ; Albers JJ
    JAMA; 1995 Dec; 274(22):1771-4. PubMed ID: 7500507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease.
    Herrmann W; Biermann J; Kostner GM
    Am J Cardiol; 1995 Sep; 76(7):459-62. PubMed ID: 7653444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients.
    Haidari M; Moghadam M; Chinicar M; Ahmadieh A; Doosti M
    Clin Biochem; 2001 Mar; 34(2):149-55. PubMed ID: 11311225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
    Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
    Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys.
    Ramharack R; Spahr MA; Sekerke CS; Stanfield RL; Bousley RF; Lee HT; Krause BK
    Atherosclerosis; 1998 Jan; 136(1):79-87. PubMed ID: 9544734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
    Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Chem Lab Med; 2008; 46(5):667-73. PubMed ID: 18598204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients.
    Baldassarre D; Tremoli E; Franceschini G; Michelagnoli S; Sirtori CR
    Stroke; 1996 Jun; 27(6):1044-9. PubMed ID: 8650712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.